• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素抗肝细胞癌作用中的铁死亡和铜死亡机制。

The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma.

机构信息

Neurosurgery Center, The National Key Clinical Specialty, The Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, The Neurosurgery Institute of Guangdong Province, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China.

Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

Molecules. 2023 Feb 8;28(4):1623. doi: 10.3390/molecules28041623.

DOI:10.3390/molecules28041623
PMID:36838613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9964324/
Abstract

BACKGROUND

Among cancer-related deaths, hepatocellular carcinoma (HCC) ranks fourth, and traditional Chinese medicine (TCM) treatment is an important complementary alternative therapy for HCC. Curcumin is a natural ingredient extracted from with anti-HCC activity, while the therapeutic mechanisms of curcumin remain unclear, especially on ferroptosis and cuproptosis.

METHODS

Differentially expressed genes (DEGs) of curcumin treatment in PLC, KMCH, and Huh7 cells were identified, respectively. The common genes among them were then obtained to perform functional enrichment analysis and prognostic analysis. Moreover, weighted gene co-expression network analysis (WGCNA) was carried out for the construction of the co-expression network. The ferroptosis potential index (FPI) and the cuproptosis potential index (CPI) were subsequently used to quantitatively analyze the levels of ferroptosis and cuproptosis. Finally, single-cell transcriptome analysis of liver cancer was conducted.

RESULTS

We first identified 702, 515, and 721 DEGs from curcumin-treated PLC, KMCH, and Huh7 cells, respectively. Among them, , , , , and may play an essential role in metal ion homeostasis. By WGCNA, grey60 co-expression module was associated with curcumin treatment and involved in the regulation of ion homeostasis. Furthermore, FPI and CPI assessment showed that curcumin had cell-specific effects on ferroptosis and cuproptosis in different HCC cells. In addition, there are also significant differences in ferroptosis and cuproptosis levels among 16 HCC cell subtypes according to single-cell transcriptome data analysis.

CONCLUSIONS

We developed CPI and combined it with FPI to quantitatively analyze curcumin-treated HCC cells. It was found that ferroptosis and cuproptosis, two known metal ion-mediated forms of programmed cell death, may have a vital effect in treating HCC with curcumin, and there are significant differences in various liver cancer cell types and curcumin treatment which should be considered in the clinical application of curcumin.

摘要

背景

在癌症相关死亡中,肝细胞癌(HCC)位居第四,中医药治疗是 HCC 的重要补充替代疗法。姜黄素是从 中提取的天然成分,具有抗 HCC 活性,而姜黄素的治疗机制尚不清楚,特别是在铁死亡和铜死亡方面。

方法

分别鉴定姜黄素处理 PLC、KMCH 和 Huh7 细胞的差异表达基因(DEGs)。然后获得它们之间的共同基因,进行功能富集分析和预后分析。此外,进行加权基因共表达网络分析(WGCNA)以构建共表达网络。随后使用铁死亡潜能指数(FPI)和铜死亡潜能指数(CPI)定量分析铁死亡和铜死亡的水平。最后,进行肝癌单细胞转录组分析。

结果

我们首先从姜黄素处理的 PLC、KMCH 和 Huh7 细胞中分别鉴定出 702、515 和 721 个 DEGs。其中, 、 、 、 和 可能在金属离子稳态中发挥重要作用。通过 WGCNA,灰色 60 共表达模块与姜黄素处理相关,参与离子稳态的调节。此外,FPI 和 CPI 评估表明,姜黄素对不同 HCC 细胞中的铁死亡和铜死亡具有细胞特异性作用。此外,根据单细胞转录组数据分析,在 16 种 HCC 细胞亚型中,铁死亡和铜死亡水平也存在显著差异。

结论

我们开发了 CPI 并结合 FPI 对姜黄素处理的 HCC 细胞进行定量分析。结果表明,铁死亡和铜死亡,两种已知的金属离子介导的程序性细胞死亡形式,可能在姜黄素治疗 HCC 中具有重要作用,并且在各种肝癌细胞类型和姜黄素治疗中存在显著差异,这在姜黄素的临床应用中应予以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/b3a2c5b99b9a/molecules-28-01623-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/bb6a722060c8/molecules-28-01623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/f79bddc692ff/molecules-28-01623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/7ccc0419d340/molecules-28-01623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/1e0d0f77622a/molecules-28-01623-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/13945a0bf08a/molecules-28-01623-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/b3a2c5b99b9a/molecules-28-01623-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/bb6a722060c8/molecules-28-01623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/f79bddc692ff/molecules-28-01623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/7ccc0419d340/molecules-28-01623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/1e0d0f77622a/molecules-28-01623-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/13945a0bf08a/molecules-28-01623-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a8/9964324/b3a2c5b99b9a/molecules-28-01623-g006.jpg

相似文献

1
The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma.姜黄素抗肝细胞癌作用中的铁死亡和铜死亡机制。
Molecules. 2023 Feb 8;28(4):1623. doi: 10.3390/molecules28041623.
2
Long non-coding RNAs in ferroptosis and cuproptosis impact on prognosis and treatment in hepatocellular carcinoma.长链非编码 RNA 在铁死亡和铜死亡中对肝癌的预后和治疗的影响。
Clin Exp Med. 2024 Jun 22;24(1):135. doi: 10.1007/s10238-024-01397-x.
3
Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma.鉴定肝细胞癌中与铜死亡相关的预后特征。
Biol Direct. 2023 Feb 7;18(1):4. doi: 10.1186/s13062-023-00358-w.
4
Research progress in cuproptosis in liver cancer.肝癌中铜死亡的研究进展。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48(9):1368-1376. doi: 10.11817/j.issn.1672-7347.2023.230083.
5
Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.铜死亡相关基因与肝细胞癌临床结局及肿瘤免疫微环境的关系。
Pathol Oncol Res. 2022 Sep 21;28:1610558. doi: 10.3389/pore.2022.1610558. eCollection 2022.
6
System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.基于铜死亡相关基因的系统分析鉴定 LIPT1 为肝癌的一个新治疗靶点。
J Transl Med. 2022 Oct 4;20(1):452. doi: 10.1186/s12967-022-03630-1.
7
Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma.全面分析肝细胞癌中铜死亡相关 lncRNAs 与免疫浸润和预后的关系。
BMC Bioinformatics. 2023 Jan 3;24(1):4. doi: 10.1186/s12859-022-05091-1.
8
Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis.铜代谢相关风险评分可识别肝细胞癌亚型,并确定溶质载体家族27成员5(SLC27A5)为铜死亡的潜在调节因子。
Aging (Albany NY). 2023 Dec 28;15(24):15084-15113. doi: 10.18632/aging.205334.
9
Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.基于铜死亡相关基因的signature 构建和分子亚型鉴定,预测肝细胞癌患者的预后和免疫活性。
Front Immunol. 2022 Sep 28;13:990790. doi: 10.3389/fimmu.2022.990790. eCollection 2022.
10
Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.铜死亡相关特征可预测肝细胞癌的预后、肿瘤微环境和药物敏感性。
J Immunol Res. 2022 Nov 16;2022:3393027. doi: 10.1155/2022/3393027. eCollection 2022.

引用本文的文献

1
Programmed Cell Death in Cancer.癌症中的程序性细胞死亡
MedComm (2020). 2025 Aug 31;6(9):e70357. doi: 10.1002/mco2.70357. eCollection 2025 Sep.
2
PSAT1 inhibits ferroptosis in osteosarcoma cells by activating the Xct/GPX4 signaling axis.PSAT1通过激活Xct/GPX4信号轴抑制骨肉瘤细胞中的铁死亡。
Sci Rep. 2025 Jul 21;15(1):26425. doi: 10.1038/s41598-025-09568-w.
3
Bibliometric analysis of programmed cell death and immunogenic cell death in hepatocellular carcinoma immunotherapy: global trends and future directions.

本文引用的文献

1
Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex.下调肝脏铜蓝蛋白可通过 SCO1-AMPK-LKB1 复合物改善非酒精性脂肪性肝病。
Cell Rep. 2022 Oct 18;41(3):111498. doi: 10.1016/j.celrep.2022.111498.
2
Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC.开发并验证 HCC 中与铜死亡相关亚型的预后模型。
Hepatol Int. 2022 Dec;16(6):1435-1447. doi: 10.1007/s12072-022-10381-0. Epub 2022 Sep 5.
3
Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer.
肝细胞癌免疫治疗中程序性细胞死亡和免疫原性细胞死亡的文献计量分析:全球趋势与未来方向
Discov Oncol. 2025 Jul 1;16(1):1208. doi: 10.1007/s12672-025-02278-9.
4
Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis.对抗癌症耐药性的策略:聚焦铜代谢与铜死亡
Cancer Drug Resist. 2025 Mar 26;8:15. doi: 10.20517/cdr.2025.41. eCollection 2025.
5
Artesunate: A Review of Its Potential Therapeutic Effects and Mechanisms in Digestive Diseases.青蒿琥酯:其在消化系统疾病中的潜在治疗作用及机制综述
Pharmaceutics. 2025 Feb 25;17(3):299. doi: 10.3390/pharmaceutics17030299.
6
Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations.姜黄素及其衍生物在肝病学中的应用:纳米颗粒制剂的治疗潜力与进展
Cancers (Basel). 2025 Feb 1;17(3):484. doi: 10.3390/cancers17030484.
7
Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications.铜死亡:分子机制、癌症预后及治疗应用
J Transl Med. 2025 Jan 22;23(1):104. doi: 10.1186/s12967-025-06121-1.
8
Trends of Copper Homeostasis in Neoplasms: A Systemic Bibliometric from 2013 to 2023.肿瘤中铜稳态的趋势:2013年至2023年的系统文献计量学分析
Biol Trace Elem Res. 2025 Jun;203(6):3445-3454. doi: 10.1007/s12011-024-04413-z. Epub 2024 Oct 9.
9
Using Bioinformatics and Machine Learning to Predict the Genetic Characteristics of Ferroptosis-Cuproptosis-Related Genes Associated with Sleep Deprivation.利用生物信息学和机器学习预测与睡眠剥夺相关的铁死亡-铜死亡相关基因的遗传特征。
Nat Sci Sleep. 2024 Sep 24;16:1497-1513. doi: 10.2147/NSS.S473022. eCollection 2024.
10
Potential Roles and Mechanisms of Curcumin and its Derivatives in the Regulation of Ferroptosis.姜黄素及其衍生物在调控铁死亡中的潜在作用和机制。
Int J Biol Sci. 2024 Sep 9;20(12):4838-4852. doi: 10.7150/ijbs.90798. eCollection 2024.
脂肪细胞衍生的外泌体 MTTP 抑制结直肠癌细胞铁死亡并促进化疗耐药性
Adv Sci (Weinh). 2022 Oct;9(28):e2203357. doi: 10.1002/advs.202203357. Epub 2022 Aug 17.
4
Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma.铜死亡相关风险评分预测肝细胞癌的预后并描绘肿瘤微环境。
Front Immunol. 2022 Jul 11;13:925618. doi: 10.3389/fimmu.2022.925618. eCollection 2022.
5
Curcumin induces mitochondrial apoptosis in human hepatoma cells through BCLAF1-mediated modulation of PI3K/AKT/GSK-3β signaling.姜黄素通过 BCLAF1 介导的对 PI3K/AKT/GSK-3β 信号的调节诱导人肝癌细胞线粒体凋亡。
Life Sci. 2022 Oct 1;306:120804. doi: 10.1016/j.lfs.2022.120804. Epub 2022 Jul 23.
6
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications.铁死亡研究十周年:新兴机制、生理功能与治疗应用
Cell. 2022 Jul 7;185(14):2401-2421. doi: 10.1016/j.cell.2022.06.003.
7
A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma.一个新的铜死亡相关 LncRNA 特征可预测肝细胞癌的预后。
Sci Rep. 2022 Jul 5;12(1):11325. doi: 10.1038/s41598-022-15251-1.
8
Impact of Zinc to Copper Ratio and Lipocalin 2 in Obese Patients Undergoing Sleeve Gastrectomy.行胃旁路术肥胖患者中锌铜比和脂联素 2 的影响。
Biomed Res Int. 2022 Jun 10;2022:9278531. doi: 10.1155/2022/9278531. eCollection 2022.
9
CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability.CRISPR/Cas9 介导的人乳腺癌细胞系 MDA-MB-231 中 Lcn2 的敲除可改善依维莫司诱导的铁死亡并增加顺铂敏感性。
Life Sci. 2022 Sep 1;304:120704. doi: 10.1016/j.lfs.2022.120704. Epub 2022 Jun 14.
10
Network Pharmacology Integrated with Transcriptomics Deciphered the Potential Mechanism of against Hepatocellular Carcinoma.网络药理学与转录组学相结合解析了[药物名称]抗肝细胞癌的潜在机制。 (你原文中“against Hepatocellular Carcinoma”前应该少了具体药物等相关内容)
Evid Based Complement Alternat Med. 2022 Mar 27;2022:1340194. doi: 10.1155/2022/1340194. eCollection 2022.